Feline infectious peritonitis

Last updated

Feline infectious peritonitis
FIPHisto1.jpg
FIP-infected kidney showing inflammatory response
Specialty Infectious diseases   OOjs UI icon edit-ltr-progressive.svg
Symptoms Initial phase: common cold-like symptoms.

Later on: ataxia, muscle weakness, dysphagia.

End phase: shortness of breath, urinary incontinence, paralysis.
Usual onsetCan take up to a year for symptoms to appear after exposure to virus
Duration1-month or less average life expectancy after diagnosis, especially in kittens
CausesMutation of feline coronavirus
TreatmentUK, Australia, Netherlands: GS-441524 (given orally as tablets) and its parent drug remdesivir (given by intravenous or subcutaneous injection) [1] [2] [3] [4]
Prognosis Usually fatal without treatment, but with GS-441524 treatment over 80% of treated cats make a full recovery.
FrequencyCommon

Feline infectious peritonitis (FIP) is a common and aberrant immune response in cats to infection with feline coronavirus (FCoV). [5]

Contents

The virus and pathogenesis of FIP

FCoV is a virus of the gastrointestinal tract. Most infections are either asymptomatic or cause diarrhea, especially in kittens, as maternally derived antibody wanes at between 5 and 7 weeks of age. The virus is a mutation of feline enteric coronavirus (FECV). From the gut, the virus very briefly undergoes a systemic phase, [6] before returning to the gut where it is shed in the feces.

The pathogenesis of FIP is complex. There is a general consensus that FIPVs arise from mutations enabling them to enter or replicate more successfully in monocytes (a type of white blood cell). However, many aspects of virus–host interactions affecting the disease remain uncertain, such as the factors that influence disease form (wet or dry), outcome (death or resistance), and host susceptibility. [7]

Virus and disease transmission

There is a lack of evidence that FIP as such is transmissible from cat to cat, although it may explain rare mini-outbreaks of FIP. [8] However, the virus, FCov, is transmissible from cat to cat.

A study on 59 FIP infected cats found that, unlike FCoV, feces from FIP infected cats were not infectious to laboratory cats via oronasal route. [9] FCoV is common in places where large groups of cats are housed together indoors (such as breeding catteries, animal shelters, etc.). The virus is shed in feces, and cats become infected by ingesting or inhaling the virus, usually by sharing cat litter trays, or by the use of contaminated litter scoops or brushes transmitting infected microscopic cat litter particles to uninfected kittens and cats. [10] FCoV can also be transmitted through different bodily fluids. The virus is easily spread through direct contact between cats. The most common form of spreading is through saliva, as most multiple cat homes share food and water dishes. [11] Another major form of spreading is grooming or fighting. When an infected cat grooms a healthy cat, it leaves its contaminated saliva on the fur. Later, when the healthy cat goes to groom themselves, it ingests the contaminated saliva and then becomes infected. [12]

Clinical signs

FIP effusive fluid Pleural effusion from a cat with feline infectious peritonitis.jpg
FIP effusive fluid

There are two main forms of FIP: effusive (wet) and non-effusive (dry). While both types are fatal, the effusive form is more common (60–70% of all cases) and progresses more rapidly than the non-effusive form.[ citation needed ]

Effusive (wet) FIP

The hallmark clinical sign of effusive FIP is the accumulation of fluid within the abdomen or chest, which can cause breathing difficulties. Other symptoms include lack of appetite, fever, weight loss, jaundice, and diarrhea.[ citation needed ]

Non-effusive (dry) FIP

Dry FIP will also present with lack of appetite, fever, jaundice, diarrhea, and weight loss, but there will not be an accumulation of fluid. Typically a cat with dry FIP will show ocular or neurological signs. For example, the cat may develop difficulty in standing up or walking, becoming functionally paralyzed over time. Loss of vision is another possible outcome of the disease.[ citation needed ]

Diagnosis

Cytology of FIP-induced fluid showing neutrophils, macrophages and lymphocytes FIPCytology2.jpg
Cytology of FIP-induced fluid showing neutrophils, macrophages and lymphocytes

Diagnosing effusive FIP

Diagnosis of the effusive form of the disease has become more straightforward in recent years. Detection of viral RNA in a sample of the effusion (liquid drained from body), such as by reverse transcription polymerase chain reaction (RT-PCR) is diagnostic of effusive FIP. [13] [14] [15] However, that does require that a sample be sent to an external veterinary laboratory. Within the veterinary hospital there are a number of tests which can rule out a diagnosis of effusive FIP within minutes:

  1. Measure the total protein in the effusion: if it is less than 35 g/L, FIP is extremely unlikely.
  2. Measure the albumin to globulin ratio in the effusion: if it is over 0.8, FIP is ruled out; if it is less than 0.4, FIP is a possible—but not certain—diagnosis. [16]
  3. Examine the cells in the effusion: if they are predominantly lymphocytes (a type of white blood cell), then FIP is excluded as a diagnosis.

Diagnosing non-effusive FIP

Non-effusive FIP is more difficult to diagnose than effusive FIP because the clinical signs tend to be more vague and varied: the list of differential diagnoses is therefore much longer. Non-effusive FIP diagnosis should be considered when the following criteria are met: [16]

  1. History: the cat is young (under 2 years old) and purebred: over 70% of cases of FIP are in pedigree kittens.[ citation needed ]
  2. History: the cat experienced stress such as recent neutering or vaccination [17]
  3. History: the cat had an opportunity to become infected with FCoV, such as originating in a breeding or rescue cattery, or the recent introduction of a purebred kitten or cat into the household.
  4. Clinical signs: the cat has become anorexic or is eating less than usual; has lost weight or failed to gain weight; has a fever of unknown origin; intra-ocular signs; jaundice. [18]
  5. Biochemistry: hypergammaglobulinaemia; raised bilirubin without liver enzymes being raised.
  6. Hematology: lymphopenia; non-regenerative—usually mild—anaemia.
  7. Serology: the cat has a high antibody titre to FCoV: this parameter should be used with caution, because of the high prevalence of FCoV in breeding and rescue catteries.

Non-effusive FIP can be ruled out as a diagnosis if the cat is seronegative, provided the antibody test has excellent sensitivity. In a study which compared various commercially available in-house FCoV antibody tests, [19] the FCoV Immunocomb (Biogal) was 100% sensitive; the Speed F-Corona rapid immunochromatographic (RIM) test (Virbac) was 92.4% sensitive and the FASTest feline infectious peritonitis (MegaCor Diagnostik) RIM test was 84.6% sensitive.

Treatment

Eight-month-old kitten in end stage "dry" FIP, who had signs of anemia, lethargy, and weight loss. She exhibited eye changes (widening and paralysis of pupils) during seizures. FIP kitten.jpg
Eight-month-old kitten in end stage "dry" FIP, who had signs of anemia, lethargy, and weight loss. She exhibited eye changes (widening and paralysis of pupils) during seizures.

Because FIP is an immune-mediated disease, treatment falls into two categories: direct action against the virus itself and modulation of the immune response.

Antiviral drugs

Antivirals (in the narrow sense) act by interfering with the enzymes or other biological processes in the FIP virus.

GS-441524 and remdesivir

An experimental drug called GS-441524 was used in a field experiment of 31 cats. After 25 days, five cats had died, eight had been cured and subsequently relapsed, and 18 had been cured without any subsequent relapses. The eight who relapsed were treated again, some with higher doses. Of these eight, one died and seven were cured, meaning that 25 of the 31 cats were ultimately cured of FIP. Although the drug is not yet (as of 2024) commercially available in the United States, the FDA allows its usage under certain conditions. [20] This study is considered very promising and may lead to commercially available medication for the treatment of FIP. [21]

In several countries oral GS-441524 tablets (and its injectable prodrug remdesivir) became legally available to vets for the treatment of FIP in cats, for example in Australia, [22] the Netherlands, [23] [lower-alpha 1] and the United Kingdom (since August 2021). [22] In naturally infected cats, a recovery rate of over 80% has been observed with GS-441524 treatment in several studies and in treatment programs in countries where the drug is legalised. [22] [25] [26] [27]

GC376

An experimental antiviral drug called GC376 was used in a field trial of 20 cats: seven cats went into remission, and 13 cats responded initially but relapsed and were euthanized. This drug is not yet (as of 2017) commercially available. [28]

Molnupiravir

Facing a high-fatality FCoV-23 outbreak on the island nation of Cyprus, on 8 August 2023 the government released 80,000 anti-COVID molnupiravir pills from its national COVID-19 stockpile, in a bid to solve the feline coronavirus crisis in a more cost-effective manner. [29]

Immunostimulants

Immunostimulants are drugs that make the immune system more active against the virus. The most common drugs of this class for treating FIP are either recombinant feline interferon omega (Virbagen Omega, Virbac) or human interferon alfa-2b. Since the human version ends up being targeted by the immune system for being a foreign antigen, the feline version feline interferon is more effective. [30]

An experimental polyprenyl immunostimulant (PI) is manufactured by Sass and Sass and tested by Dr. Al Legendre, who described survival over 1 year in three cats diagnosed with FIP and treated with the medicine. [31] In a subsequent field study of 60 cats with non-effusive FIP treated with PI, 52 cats (87%) died before 200 days, but eight cats survived over 200 days from the start of PI treatment for and four of those survived beyond 300 days. [32]

Anti-inflammatory drugs

It is recommended to use an anti-inflammatory drug against FIP. [33]

Immunosuppressive drugs dampen the immune system, helping to reduce inflammation. The go-to immunosuppressive drug in FIP is prednisolone, a corticosteroid. There are no placebo-controlled trials showing prednisolone to be better than other anti-inflammatories. [33]

Prevention

Vaccination

There is no effective vaccine against FIPV. DNA vaccination with plasmids encoding FIPV proteins failed to produce immunity. [34] Rather, it was observed that antibodies to the FIPV spike protein exacerbate the disease.

In film

A 2018 film titled Aeris, by Paul Castro Jr. and Aly Miller, and starring Frank Deal, Arabella Oz and Betsy Aidem, is about a kitten born with FIP that is purchased from a pet store and the owners' twelve days with it. [35] [36] The film received an award at the 2018 Garden State Film Festival in the Narrative Short category [37] and was a Gold Kahuna winner at the 2018 Honolulu Film Awards. [38]

See also

Explanatory notes

  1. ↑ At the moment, legal treatment with GS-441524 in the Netherlands is only available through vets from the Veterinary medicine department of Utrecht University. The drug is made in the University pharmacy. After a successful trial period starting in June 2023, the drug will become legally available for FIP treatment in cats to all vets in the country. Remdesivir can be legally used for treatment by all vets in the Netherlands under the cascade, [24] since its approval for the use in human COVID-19 treatment.

Related Research Articles

<span class="mw-page-title-main">Coronavirus</span> Subfamily of viruses in the family Coronaviridae

Coronaviruses are a group of related RNA viruses that cause diseases in mammals and birds. In humans and birds, they cause respiratory tract infections that can range from mild to lethal. Mild illnesses in humans include some cases of the common cold, while more lethal varieties can cause SARS, MERS and COVID-19. In cows and pigs they cause diarrhea, while in mice they cause hepatitis and encephalomyelitis.

<span class="mw-page-title-main">Feline immunodeficiency virus</span> Species of virus

Feline immunodeficiency virus (FIV) is a Lentivirus that affects cats worldwide, with 2.5% to 4.4% of felines being infected.

<i>Feline leukemia virus</i> Species of virus

Feline leukemia virus (FeLV) is a retrovirus that infects cats. FeLV can be transmitted from infected cats when the transfer of saliva or nasal secretions is involved. If not defeated by the animal's immune system, the virus weakens the cat's immune system, which can lead to diseases which can be lethal. Because FeLV is cat-to-cat contagious, FeLV+ cats should only live with other FeLV+ cats.

<span class="mw-page-title-main">Opportunistic infection</span> Infection caused by pathogens that take advantage of an opportunity not normally available

An opportunistic infection is an infection caused by pathogens that take advantage of an opportunity not normally available. These opportunities can stem from a variety of sources, such as a weakened immune system, an altered microbiome, or breached integumentary barriers. Many of these pathogens do not necessarily cause disease in a healthy host that has a non-compromised immune system, and can, in some cases, act as commensals until the balance of the immune system is disrupted. Opportunistic infections can also be attributed to pathogens which cause mild illness in healthy individuals but lead to more serious illness when given the opportunity to take advantage of an immunocompromised host.

<i>Carnivore protoparvovirus 1</i> Species of parvovirus

Carnivore protoparvovirus 1 is a species of parvovirus that infects carnivorans. It causes a highly contagious disease in both dogs and cats separately. The disease is generally divided into two major genogroups: FPV containing the classical feline panleukopenia virus (FPLV), and CPV-2 containing the canine parvovirus type 2 (CPV-2) which appeared in the 1970s.

<span class="mw-page-title-main">Canine parvovirus</span> Contagious virus mainly affecting dogs

Canine parvovirus is a contagious virus mainly affecting dogs and wolves. CPV is highly contagious and is spread from dog to dog by direct or indirect contact with their feces. Vaccines can prevent this infection, but mortality can reach 91% in untreated cases. Treatment often involves veterinary hospitalization. Canine parvovirus often infects other mammals including foxes, wolves, cats, and skunks. Felines (cats) are also susceptible to panleukopenia, a different strain of parvovirus.

Cerebellar hypoplasia (CH) is a neurological condition in which the cerebellum is smaller than usual or not completely developed. It has been reported in many animal species.

<span class="mw-page-title-main">Canine coronavirus</span> Species of virus

Canine coronavirus (CCoV) is an enveloped, positive-sense, single-stranded RNA virus which is a member of the species Alphacoronavirus 1. It causes a highly contagious intestinal disease worldwide in dogs. The infecting virus enters its host cell by binding to the APN receptor. It was discovered in 1971 in Germany during an outbreak in sentry dogs. The virus is a member of the genus Alphacoronavirus and subgenus Tegacovirus.

<span class="mw-page-title-main">Feline viral rhinotracheitis</span> Infectious disease of cats

Feline viral rhinotracheitis (FVR) is an upper respiratory or pulmonary infection of cats caused by Felid alphaherpesvirus 1 (FeHV-1), of the family Herpesviridae. It is also commonly referred to as feline influenza, feline coryza, and feline pneumonia but, as these terms describe other very distinct collections of respiratory symptoms, they are misnomers for the condition. Viral respiratory diseases in cats can be serious, especially in catteries and kennels. Causing one-half of the respiratory diseases in cats, FVR is the most important of these diseases and is found worldwide. The other important cause of feline respiratory disease is feline calicivirus.

<span class="mw-page-title-main">Cat health</span> Health of domestic cats

The health of domestic cats is a well studied area in veterinary medicine.

Feline coronavirus (FCoV) is a positive-stranded RNA virus that infects cats worldwide. It is a coronavirus of the species Alphacoronavirus 1, which includes canine coronavirus (CCoV) and porcine transmissible gastroenteritis coronavirus (TGEV). FCoV has two different forms: feline enteric coronavirus (FECV), which infects the intestines, and feline infectious peritonitis virus (FIPV), which causes the disease feline infectious peritonitis (FIP).

<span class="mw-page-title-main">Remdesivir</span> Antiviral drug

Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. During the COVID‑19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 in numerous countries.

Feline foamy virus or Feline syncytial virus is a retrovirus and belongs to the family Retroviridae and the subfamily Spumaretrovirinae. It shares the genus Felispumavirus with only Puma feline foamy virus. There has been controversy on whether FeFV is nonpathogenic as the virus is generally asymptomatic in affected cats and does not cause disease. However, some changes in kidney and lung tissue have been observed over time in cats affected with FeFV, which may or may not be directly affiliated. This virus is fairly common and infection rates gradually increase with a cat's age. Study results from antibody examinations and PCR analysis have shown that over 70% of felines over 9 years old were seropositive for Feline foamy virus. Viral infections are similar between male and female domesticated cats whereas in the wild, more feral females cats are affected with FeFV.

<span class="mw-page-title-main">GC376</span> Broad-spectrum antiviral medication

GC376 is a broad-spectrum antiviral medication under development by the biopharmaceutical company Anivive Lifesciences for therapeutic uses in humans and animals. Anivive licensed the exclusive worldwide patent rights to GC376 from Kansas State University. As of 2020, GC376 is being investigated as a treatment for COVID-19. GC376 shows activity against many human and animal viruses, including coronavirus and norovirus; the most extensive research has been multiple in vivo studies in cats treating a coronavirus, which causes deadly feline infectious peritonitis. Other research supports use in porcine epidemic diarrhea virus.

<span class="mw-page-title-main">Convalescent plasma</span> Blood plasma from disease survivor

Convalescent plasma is the blood plasma collected from a survivor of an infectious disease. This plasma contains antibodies specific to a pathogen and can be used therapeutically by providing passive immunity when transfusing it to a newly infected patient with the same condition. Convalescent plasma can be transfused as it has been collected or become the source material for hyperimmune serum or anti-pathogen monoclonal antibodies; the latter consists exclusively of IgG, while convalescent plasma also includes IgA and IgM. Collection is typically achieved by apheresis, but in low-to-middle income countries, the treatment can be administered as convalescent whole blood.

<span class="mw-page-title-main">GS-441524</span> Metabolite of remdesivir

GS-441524 is a nucleoside analogue antiviral drug which was developed by Gilead Sciences. It is the main plasma metabolite of the antiviral prodrug remdesivir, and has a half-life of around 24 hours in human patients. Remdesivir and GS-441524 were both found to be effective in vitro against feline coronavirus strains responsible for feline infectious peritonitis (FIP), a lethal systemic disease affecting domestic cats. Remdesivir was never tested in cats, but GS-441524 has been found to be effective treatment for FIP.

<span class="mw-page-title-main">History of coronavirus</span> History of the virus group

The history of coronaviruses is an account of the discovery of the diseases caused by coronaviruses and the diseases they cause. It starts with the first report of a new type of upper-respiratory tract disease among chickens in North Dakota, U.S., in 1931. The causative agent was identified as a virus in 1933. By 1936, the disease and the virus were recognised as unique from other viral disease. They became known as infectious bronchitis virus (IBV), but later officially renamed as Avian coronavirus.

<i>Alphacoronavirus 1</i> Species of virus

Alphacoronavirus 1 is a species of coronavirus that infects cats, dogs and pigs. It includes the virus strains feline coronavirus, canine coronavirus, and transmissible gastroenteritis virus. It is an enveloped, positive-strand RNA virus which is able to enter its host cell by binding to the APN receptor.

<span class="mw-page-title-main">Nirmatrelvir</span> COVID-19 antiviral medication

Nirmatrelvir is an antiviral medication developed by Pfizer which acts as an orally active 3C-like protease inhibitor. It is part of a nirmatrelvir/ritonavir combination used to treat COVID-19 and sold under the brand name Paxlovid.

References

  1. ↑ Hartmann 2017. Coronavirus Infections (Canine and Feline), Including Feline Infectious Peritonitis. Chapter 224 p984-991. In Textbook of Internal Medicine, 4th Edition. Ettinger.
  2. ↑ Kennedy and Little 2012. Infectious diseases, Chapter 33 p1038-1047. In The Cat. Clinical Medicine and Management, Little.
  3. ↑ Pederson et al 2019. Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J Feline Med Surg.21: 271–281
  4. ↑ Dickinson et al 2020. Antiviral treatment using the adenosine nucleoside analogue GS‐441524 in cats with clinically diagnosed neurological feline infectious peritonitis J Vet Intern Med. 2020 Jul; 34(4): 1587–1593
  5. ↑ Addie, D.; Belák, S.; Boucraut-Baralon, C.; Egberink, H.; Frymus, T.; Gruffydd-Jones, T.; Hartmann, K.; Hosie, M. J.; Lloret, A. (11 July 2009). "Feline infectious peritonitis. ABCD guidelines on prevention and management". Journal of Feline Medicine and Surgery. 11 (7): 594–604. doi:10.1016/j.jfms.2009.05.008. PMC   7129471 . PMID   19481039.
  6. ↑ Porter, E.; Tasker, S.; Day, M. J.; Harley, R.; Kipar, A.; Siddell, S. G.; Helps, C. R. (25 April 2014). "Amino acid changes in the spike protein of feline coronavirus correlate with systemic spread of virus from the intestine and not with feline infectious peritonitis". Veterinary Research. 45 (1). BiomedCentral: 49. doi: 10.1186/1297-9716-45-49 . PMC   4006447 . PMID   24767677.
  7. ↑ Pedersen, N. C. (August 2014). "An update on feline infectious peritonitis: Virology and immunopathogenesis". The Veterinary Journal. 201 (2): 123–132. doi:10.1016/j.tvjl.2014.04.017. PMC   7110662 . PMID   24837550.
  8. ↑ Pedersen, Niels C. (2014). "An update on feline infectious peritonitis: Virology and immunopathogenesis". The Veterinary Journal. 201 (2). Transmission of feline infectious peritonitis virus. doi:10.1016/j.tvjl.2014.04.017. PMC   7110662 . PMID   24837550. S2CID   23453920.
  9. ↑ Pedersen, Niels C.; Liu, Hongwei; Scarlett, Jennifer; Leutenegger, Christian M.; Golovko, Lyudmila; Kennedy, Heather; Kamal, Farina Mustaffa (2012). "Feline infectious peritonitis: Role of the feline coronavirus 3c gene in intestinal tropism and pathogenicity based upon isolates from resident and adopted shelter cats". Virus Research. 165 (1). 4.2. Role of the 3c gene of FECVs and FIPVs in intestinal tropism and fecal shedding. doi:10.1016/j.virusres.2011.12.020. PMC   7114484 . PMID   22280883.
  10. ↑ "How cats become infected with feline coronavirus: animation". 18 August 2011. Archived from the original on 21 December 2021 – via YouTube.
  11. ↑ "Feline Infectious Peritonitis (FIP) Transmission - Feline Infectious Peritonitis (FIP)". HealthCommunities. Retrieved 2 November 2018.
  12. ↑ "FIP". The Cat Community. Retrieved 2 November 2018.
  13. ↑ Felten, S.; Leutenegger, C. M.; Balzer, H-J; Pantchev, N.; Matiasek, K.; Wess, G.; Egberink, H.; Hartmann, K. (2 August 2017). "Sensitivity and specificity of a real-time reverse transcriptase polymerase chain reaction detecting feline coronavirus mutations in effusion and serum/plasma of cats to diagnose feline infectious peritonitis". Veterinary Research. 13 (1). BiomedCentral: 228. doi: 10.1186/s12917-017-1147-8 . PMC   5541694 . PMID   28768514.
  14. ↑ Doenges, S. J.; Weber, K.; Dorsch, R.; Fux, R.; Hartmann, K. (1 April 2017). "Comparison of real-time reverse transcriptase polymerase chain reaction of peripheral blood mononuclear cells, serum and cell-free body cavity effusion for the diagnosis of feline infectious peritonitis" (PDF). Journal of Feline Medicine and Surgery. 19 (4): 344–350. doi:10.1177/1098612X15625354. PMC   11119647 . PMID   26787293. S2CID   7136727.
  15. ↑ Longstaff, L.; Porter, E.; Crossley, V. J.; Hayhow, S. E.; Helps, C. R.; Tasker, S. (16 October 2015). "Feline coronavirus quantitative reverse transcriptase polymerase chain reaction on effusion samples in cats with and without feline infectious peritonitis". Journal of Feline Medicine and Surgery. 19 (2): 240–245. doi: 10.1177/1098612X15606957 . hdl: 1983/2cba7130-9b6c-405f-9a47-276b7a09ed1d . PMC   10816577 . PMID   26474594. S2CID   206692877.
  16. 1 2 "Dr. Addie - What is FIP?". CatVirus.com.
  17. ↑ Riemer, F.; Kuehner, K. A.; Ritz, S.; Sauter-Louis, C.; Hartmann, K. (16 July 2015). "Clinical and laboratory features of cats with feline infectious peritonitis: A retrospective study of 231 confirmed cases (2000–2010)". Journal of Feline Medicine and Surgery. 18 (4): 348–356. doi: 10.1177/1098612X15586209 . PMC   11112253 . PMID   26185109. S2CID   206692653.
  18. ↑ Addie, Diane D. (19 April 2013). Feline Infectious Peritonitis and Coronavirus: Everything a cat lover needs to know. CreateSpace Independent Publishing Platform. ISBN   9781480208971.
  19. ↑ Addie, D. D.; le Poder, S.; Burr, P.; Decaro, N.; Graham, E.; Hofmann-Lehmann, R.; Jarrett, O.; McDonald, M.; Meli, M. L. (1 February 2015). "Utility of feline coronavirus antibody tests". Journal of Feline Medicine and Surgery. 17 (2): 152–162. doi: 10.1177/1098612X14538873 . hdl: 11586/146443 . PMC   10816424 . PMID   24966245. S2CID   21831168.
  20. ↑ "FDA Announces Position on Use of Compounded GS-441524 to Treat FIP". FDA. 10 May 2024.
  21. ↑ Pedersen, N. C.; Perron, M.; Bannasch, M.; Montgomery, E.; Murakami, E.; Liepnieks, M.; Liu, H. (13 February 2019). "Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis". Journal of Feline Medicine and Surgery. 21 (4): 271–281. doi:10.1177/1098612X19825701. PMC   6435921 . PMID   30755068.
  22. 1 2 3 "Feline Infectious Peritonitis (FIP)". icatcare.org. International Cat Care. Retrieved 15 October 2023.
  23. ↑ "Nu ook in Nederland behandeling voor katten met FIP". LICG.nl (in Dutch). Landelijk InformatieCentrum Gezelschapsdieren. Retrieved 15 October 2023.
  24. ↑ "Cascade". cbg-meb.nl. Medicines Evaluation Board. 6 October 2018. Retrieved 15 October 2023.
  25. ↑ "Successful Feline Infectious Peritonitis Treatment with Remdesivir at the RVC". RVC.ac.uk. Retrieved 15 October 2023.
  26. ↑ "FIP Antivirals – Fight FIP". blogs.cornell.edu. Whittaker Lab - Cornell University . Retrieved 15 October 2023.
  27. ↑ Jones, Sarah; Novicoff, Wendy; Nadeau, Julie; Evans, Samantha (30 July 2021). "Unlicensed GS-441524-Like Antiviral Therapy Can Be Effective for at-Home Treatment of Feline Infectious Peritonitis". Animals. 11 (8): 2257. doi: 10.3390/ani11082257 . ISSN   2076-2615. PMC   8388366 . PMID   34438720.
  28. ↑ Pedersen, N. C.; Kim, Y.; Liu, H.; Galasiti Kankanamalage, A. C.; Eckstrand, C.; Groutas, W. C.; Bannasch, M.; Meadows, J. M.; Chang, K. O. (13 September 2017). "Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis". Journal of Feline Medicine and Surgery. 20 (4): 378–392. doi: 10.1177/1098612X17729626 . PMC   5871025 . PMID   28901812. S2CID   4595813.
  29. ↑ Smith, Helena (10 August 2023). "Cyprus to begin treating island's sick cats with anti-Covid pills". The Guardian. Archived from the original on 13 August 2023. Retrieved 15 August 2023.
  30. ↑ Forney, Barbara. "Interferon Alpha-2B for Veterinary Use". Wedgewood Pharmacy.
  31. ↑ Legendre, A. M.; Bartges, J. W. (1 August 2009). "Effect of Polyprenyl Immunostimulant on the survival times of three cats with the dry form of feline infectious peritonitis". Journal of Feline Medicine and Surgery. 11 (8): 624–626. doi:10.1016/j.jfms.2008.12.002. PMC   7130077 . PMID   19482534.
  32. ↑ Legendre, A. M.; Kuritz, T.; Galyon, G.; Baylor, V. M.; Heidel, R. E. (14 February 2017). "Polyprenyl Immunostimulant Treatment of Cats with Presumptive Non-Effusive Feline Infectious Peritonitis In a Field Study". Frontiers in Veterinary Science. 4: 7. doi: 10.3389/fvets.2017.00007 . PMC   5306384 . PMID   28261584. S2CID   4835088.
  33. 1 2 Hugo, T. B.; Heading, K. L. (January 2015). "Prolonged survival of a cat diagnosed with feline infectious peritonitis by immunohistochemistry". The Canadian Veterinary Journal. 56 (1): 53–8. PMC   4266056 . PMID   25565715.
  34. ↑ Glansbeek, H. L.; Haagmans, B. L.; Te Lintelo, E. G.; Egberink, H. F.; Duquesne, V.; Aubert, A.; Horzinek, M. C.; Rottier, P. J. M. (2002). "Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus". Journal of General Virology . 83 (Pt 1): 1–10. doi: 10.1099/0022-1317-83-1-1 . PMID   11752695.
  35. ↑ "Aeris (2018)". Rotten Tomatoes .
  36. ↑ "The Story of Aeris: A Legacy Inspired by Love". The Purrington Post. 30 November 2016.
  37. ↑ "Garden State Film Festival 2018 Winners". New Jersey Stage. 10 April 2018.
  38. ↑ "2018 Winners, 2018 Gold Kahuna Winners". Honolulu Film Awards.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.